AI governance, documented for every funding stage.
AI oversight needs an interdisciplinary foundation that connects R&D, regulatory, operations, risk and legal. Few scaling companies can assemble that team on their own.
DP5 Govern supplies the foundation as governance documents matched to each funding stage. A real-time portal platform is in development.
DP5 applies its proof-before-purchase standard to governance. Each document set gives a board, investor or partner evidence to review before approving the next business step.
PhD, Molecular and Cellular Biology (ASU) · AIGP (IAPP) · PMP · 3x co-founder. Read more on the About page.
Choose the group that matches yours.
AI enters research, product development and daily operations faster than companies can record who approved each model, which data trained it, who is accountable at each stage and how its performance changes over time. Investors, partners, IP counsel and regulators ask for those records at moments central to growth: financing rounds, partnerships, patent filings and regulatory submissions.
DP5 delivers governance documents matched to the company's funding stage, beginning at seed with an inventory of every AI system in use. Biotech teams also receive a regulatory scope screen. Invention records support IP protection and are designed for review by the client's patent counsel. Real-time dashboards and an executive portal are in development.
The right documents at each funding stage.
Each document is sized for teams of 10 to 150 people. DP5 prepares every document informed by ISO/IEC 42001, the NIST AI Risk Management Framework along with AI guidance from the FDA (including the January 2025 draft guidance), the USPTO and other agencies.
Seed
The foundation for every company.A register of every AI tool, model and use in the company, with its owner, purpose and status.
Sets how the company selects, approves and uses AI, and how staff raise concerns.
A record of human contributions to AI-assisted work, automated where possible and designed for review by the client's patent counsel. Applies to any company patenting AI-assisted work.
Short questions showing whether an AI use stays in discovery or might fall under FDA guidance or the EU AI Act.
Plain-language descriptions of what each AI system does, how well it performs and where it falls short.
Series A
Adds the following to the seed set.Rates each AI use by the likelihood and severity of harm and records the controls chosen.
Names who proposes, approves and monitors each AI use.
A checklist that moves each AI project from proposal to retirement, with a named approver at each gate.
Records where AI data came from, how it was processed, and which rights and consents apply throughout the lifecycle.
Questions for vetting AI vendors and the models built into software the company buys.
Series B and later
Adds the following to the Series A set.How the company tracks AI performance, handles incidents and manages changes after launch.
Validation evidence for AI outputs used in nonclinical, clinical or manufacturing data. Added once an AI use becomes regulatory facing.
Investors and programs
For VC firms, incubators and accelerators.A question set for VCs, with a guide to what strong AI governance evidence looks like at each stage.
A short intake that helps incubators decide which governance documents each company needs before investor meetings.
Scope and pricing depend on company size and the complexity of the work. The Discovery Call sets both.
Real-time visibility across AI projects.
DP5 is building encrypted, password-protected portals that give leadership one place to see AI use across the company. These tools are in development, and the document sets above are available now.
Streams model performance, data drift alerts, model approvals and flagged compliance issues into the executive portal.
Shows leadership each AI project's lifecycle stage from proposal through retirement, its model performance health and the decisions still open.
Maps company processes against industry-accepted frameworks and flags items for review with counsel.
Each portal is encrypted, password protected and delivered to the client company. The client decides whether to share access with investors, programs or other external groups.
Disclaimer. DP5 works alongside each client's legal and regulatory counsel as needed. DP5 does not provide legal advice. Points involving patents, regulatory submissions or contracts are prepared for discussion with qualified counsel.
Alignment notice. DP5 prepares each document in good faith against current standards, frameworks and agency guidance on AI, which continue to evolve. Outcomes such as certification or regulatory acceptance depend on factors beyond any single document, so DP5 does not guarantee them.
See what AI governance looks like for your group.
Book a free Discovery Call to see what a governance document set looks like for your organization and where the real-time portals are headed.